Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2018

Oct 24, 2018

32870_dirs_2018-10-24_feb98d1d-d967-4447-9166-5ba2beb0870b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-10-17

Reporting Person: Havey Adam (EVP, Business Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-10-17 Common Stock S 314 $63.50 Disposed 29253 Direct

Footnotes

F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.

F2: This form 4/A is being filed to amend the sales price of the shares.